Studies in breast cancer survivors have demonstrated that weight-loss interventions preferentially decreased leptin levels (-35.6%) and increased the adiponectin-to-leptin ratio (10.6%), independent of changes in absolute adiponectin levels [48]. The gene discussed is ADIPOQ; the disease is breast cancer.